Dear Sir, We read with interest the most recent chapter in the controversy about the physiological significance of insulin-mediated vasodilation and the conflicting views of the groups headed by Yki-Jarvinen and Baron [1, 2, 3] . Baron cites our work on the reproducibility of plethysmography [4] in support of his argument that vasodilation caused by physiological concentrations of insulin will be detectable only at pharmacological concentrations if the method of flow measurement is insensitive [2] . It is, however, a serious misrepresentation to condense our detailed examination of the between-day, intra-subject reproducibility of bilateral compared with unilateral forearm plethysmography into the statement that ªplethysmography has a coefficient of variation of 40 %º.
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Forearm plethysmography is a widely used method in clinical investigation but few investigators have attempted to show whether or not it is reproducible. Although some authors quote a coefficient of variation (CV) for measurement of forearm blood flow (FBF) in the methods section of their papers, it is seldom clear how such a measurement was derived. We surmise from our own investigations that such figures are often based on within-day reproducibility of serial FBF measurements, even though the corresponding study designs frequently aim to detect differences between days, e. g. comparison of blood flow responses to a particular agonist under different experimental conditions or before and after a period of intervention. Clearly there is considerable day-to±day variability in blood flow: a proportion of that variability is ªtrueº variation and the rest is due to measurement error. Both components are likely to be much larger if the repeated measurements are made on a separate day. Our methodological paper contains the only published between-day, intra-subject reproducibility data for plethysmography-derived measurements of FBF from a non-selected series of untrained volunteers.
Briefly, our study showed that use of the non-infused arm as a concurrent control with expression of data as forearm blood flow (FBF) ratios resulted in an improvement in between-day, intra-subject variability (CV) from 31 % to 19 % [4] . A similar improvement was observed for dose-response curves to intraarterially infused agonists. Comparing our measurement with those from other laboratories, we note that a CV of 12 % was quoted in a recent paper by Baron for measurement of leg blood flow using his thermodilution technique with a patented double-lumen femoral vein catheter [5] .
It is not stated whether this figure was derived from between-day or within-day measurements in non-selected subjects: thus it is unclear whether or not this result is directly comparable with our study. In turn, the CV of 13 % cited by Yki-Jarvinen in the recent correspondence [3] is based on a within-day reproducibility study for unilateral plethysmography [6] . Such a figure is entirely consistent with much higher values for between-day, intra-subject variability and although it could be true that plethysmography is more reproducible in her laboratory than in others, this cannot be established from the evidence cited.
In a recent double-blind, placebo-controlled study, we have shown early insulin-mediated vasodilation reaching 50 % above baseline flow by 40 min at insulin concentrations of 500 pmol/l [7] . This effect was observed during co-infusion of low dose physiological d-glucose at a rate sufficient to maintain near euglycaemia in the forearm venous effluent. It was not observed when the stereoisomer l-glucose, which is not recognised by glucose transporters, was substituted. This observation addresses the wider issue of the current debate. Discrepancies between euglycaemic clamp thermodilution studies in the leg and insulin infusion plethysmography studies in the forearm regarding the magnitude (or even presence) of insulin-mediated vasodilation are probably not related to the method of measurement of flow. Rather, it appears that an unphysiological dissociation between local glucose and insulin concentrations occurs when insulin alone is infused intra-arterially. Our data suggest that tissue glucose uptake is a determinant of the magnitude of insulin vasodilation: this is maintained during leg studies when glucose is infused systemically but not during local forearm insulin infusions. This could be one of the reasons why some early studies failed to detect insulin-mediated vasodilation in the forearm even though it does not explain the lack of such an effect in an earlier study by Yki-Jarvinen et al. in which blood flow was measured unilaterally using forearm plethysmography [8] .
Yours sincerely, J. R. Petrie, S. J. Cleland, Sh.Ueda, H. L. Elliott, J. M. C. Connell
